Monday, September 14, 2026

Daewoong Pharmaceutical holds “Nabota Master Class,” demonstrates proprietary procedures

Daewoong Pharmaceutical hosted the "Nabota Master Class" for 74 medical professionals from 13 countries, focusing on safety and clinical application.

We Gonna Shoot! Is North Korea’s Latest Missile Test a Warning? Analyzing the Impact Ahead of APEC 2025

North Korea resumed missile launches, firing an unidentified ballistic missile, marking its first test in over five months ahead of APEC.

2026 PRP Kit Revolution: How Humedix and Medisarang Are Transforming Regenerative Medicine

Humedics and Medisarang partner to develop regenerative medicine devices, focusing on PRP kits for aesthetics and other medical fields.

Intel Stock Tumbles Following Reports of Stricter Export Controls to China

EtcIntel Stock Tumbles Following Reports of Stricter Export Controls to China
Yahoo Finance
Yahoo Finance

Intel Corporation’s stock plunged more than 5% following reports that the Trump administration plans to tighten semiconductor export controls to China.

On Tuesday, Intel shares fell 5.27% to $22.99 on the New York Stock Exchange.

The company had recently experienced a stock rally, driven by speculation that Broadcom and Taiwan’s TSMC might pursue a split acquisition of Intel.

However, the stock took a significant downturn after Bloomberg reported that the Trump administration plans to impose further restrictions on semiconductor exports.

China is a critical market for Intel, with sales reaching $15 billion last year.

If the Trump administration tightens semiconductor export controls to China, it will significantly damage Intel’s revenue. A sharp decline in sales from China, in particular, could inflict even greater damage on Intel, which is already struggling with management challenges.

These concerns likely triggered the sharp drop in Intel’s stock price. Despite this setback, Intel’s shares have risen 10.37% over the past month.

Check Out Our Content

Check Out Other Tags:

Most Popular Articles